A SUA ENCOMENDA
O seu carrinho está vazio
Comece a adicionar peptídeos de investigação ao seu carrinho.
PODERÁ TAMBÉM GOSTAR
O seu carrinho está vazio
Comece a adicionar peptídeos de investigação ao seu carrinho.
PODERÁ TAMBÉM GOSTAR
NewTriple Receptor Research Peptide · 1-2-Day Delivery to Brighton
A triple receptor agonist (GLP-1 / GIP / Glucagon) investigated in early-phase metabolic research. Studies suggest Retatrutide may modulate appetite, glucose homeostasis, and energy expenditure through three independent incretin pathways. ORYN Retatrutide delivers 5mg/3ml in a reusable pen system with precision dosing for 30 days.
Retatrutide is the most extensively studied tri-incretin compound to date. It activates GLP-1, GIP, and glucagon receptors simultaneously — adding a glucagon-receptor arm to the dual mechanism of Tirzepatide. Early-phase research suggests this triple action may modulate appetite, glucose homeostasis, and energy expenditure through three independent incretin pathways at once.
LOCAL PRICING
From £134 UK · €156 EU · $169 US · R$ 1.300 BR. All prices include customs and shipping within the destination region, no hidden fees at the door.
RESEARCH FOCUS
Retatrutide (LY3437943) is a single-molecule triple agonist that simultaneously activates three incretin and metabolic hormone receptors: the glucose-dependent insulinotropic polypeptide receptor (GIPR), the glucagon-like peptide-1 receptor (GLP-1R), and the glucagon receptor (GCGR). This triple mechanism differentiates it from dual agonists like tirzepatide, which target only GIP and GLP-1 receptors. GLP-1R activation suppresses appetite centrally via hypothalamic signalling, slows gastric emp…
DISPATCH & DELIVERY
Order by 14:00 GMT for next-day dispatch. Saturday delivery available on request.
ORYN delivers Retatrutide peptide pens directly to Brighton with 1-2-day tracked delivery. Order online at orynpeptides.com and receive your pre-mixed, research-grade pen at your door.
ORYN Retatrutide is priced at €169 per pen, which contains a 30-day supply of 5 mg in a pre-mixed, ready-to-use pen system. Free UK delivery on orders over €175.
Yes, Retatrutide is legal to purchase for research purposes in Brighton and across the UK. ORYN products are sold strictly for research use only.
ORYN Retatrutide exceeds 99% purity, verified by independent HPLC analysis. Each batch comes with a Certificate of Analysis from a third-party laboratory.
Retatrutide is a triple agonist (GLP-1 + GIP + glucagon receptors) while Tirzepatide is dual (GLP-1 + GIP). Adding glucagon-receptor activation may further increase energy expenditure and lipid mobilisation. Phase-2 trials reported up to 24% body weight reduction vs Tirzepatide's ~22.5%.
5 mg covers a full 30-day dose-titration block at phase-2 schedules: starting at 0.5 mg weekly and escalating in 4-week intervals up to the target research dose.
1-2-daytracked delivery. Pre-mixed & ready to use. >99% purity guaranteed.
ORDER RETATRUTIDE — €169
